Table 5.

Clinical characteristics and fasting lipid and glucose levels of the of the PCSK9 mutation carriers and noncarriers in the primary dyslipidemia group

Clinical data	PCSK9 (+)	PCSK9 (–)	P-value
	n=25	n=175
Age, years	52.6±12.9	49.8±13.2	-
Female, n, %	10 (40.0%)	95 (54.3% )	-
Male, n, %	15 (60.0%)	80 (45.7%)	-
CVD, n, %	10 (33.3%)	52 (30.6%)	0.125
Total cholesterol	312.6±92.4	318.67±107.9	0.791
Triglycerides	213.4±110.1	163.4±81.8	0.007
HDL cholesterol	48.5±11.4	50.2±13.1	0.532
LDL cholesterol	228.8±78	238.5±99.3	0.643
Fasting glucose	95.4±13.4	95.8±15.1	0.886

CVD - cardiovascular disease, HDL-C - high-density lipoprotein cholesterol, LDL-C - low-density lipoprotein cholesterol